Swiss National Bank Sells 154,200 Shares of UnitedHealth Group Incorporated $UNH

Swiss National Bank decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,614,861 shares of the healthcare conglomerate’s stock after selling 154,200 shares during the period. UnitedHealth Group comprises about 0.5% of Swiss National Bank’s investment portfolio, making the stock its 25th biggest position. Swiss National Bank owned 0.29% of UnitedHealth Group worth $902,912,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. LFA Lugano Financial Advisors SA purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth about $25,000. Sagard Holdings Management Inc. purchased a new stake in UnitedHealth Group in the second quarter worth approximately $29,000. Foster Dykema Cabot & Partners LLC increased its holdings in shares of UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 34 shares during the period. Islay Capital Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter valued at $31,000. Finally, Hurley Capital LLC raised its position in UnitedHealth Group by 81.6% during the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $286.86 on Monday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. The company has a market capitalization of $260.38 billion, a PE ratio of 21.75, a price-to-earnings-growth ratio of 1.32 and a beta of 0.41. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The business’s fifty day moving average is $308.28 and its 200 day moving average is $326.02.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The company had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm’s revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the company earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 3.1%. UnitedHealth Group’s dividend payout ratio (DPR) is 67.02%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. Truist Financial cut their price target on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Weiss Ratings lowered shares of UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. Morgan Stanley lowered their price objective on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research report on Friday, January 23rd. JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a research report on Monday, February 2nd. Finally, UBS Group reduced their price objective on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $372.13.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.